S824 A PHASE 3 RANDOMIZED, OPEN-LABEL, MULTICENTER STUDY OF ISATUXIMAB, POMALIDOMIDE, AND LOW-DOSE DEXAMETHASONE VS POMALIDOMIDE AND LOW-DOSE DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)
暂无分享,去创建一个
M. Dimopoulos | P. Richardson | P. Moreau | X. Leleu | H. Prince | J. Huang | J. San-Miguel | M. Attal | M. Cavo | S. Rajkumar | I. Špička | F. Schjesvold | J. Minařík | S. Macé | K. Corzo | F. Campana | Solenn Le-Guennec | F. Dubin | K. Anderson | M. Beksaç | I. Spicka